About Teletype
Join
Acumen Research
@acumenresearchmarket2019
Market Research Report
January 10, 2020

Transcatheter Devices Market Surge at 12% CAGR and Hit $ 19.4 Billion By 2027

Transcatheter Devices Market (By Product: Transcatheter embolization and occlusion devices, Transcatheter replacement devices, Transcatheter repair devices; By Application: Cardiovascular, Oncology, Neurology, Urology, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2027

The global Transcatheter Devices Market Size is anticipated to around USD 19.4 billion by 2027, this market is anticipated to grow with 12% CAGR during the forecast time period.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1659

North America dominated the global transcatheter devices market in the year 2018. The region has experienced the potential growth owing to the presence of higher adoption of technological advance devices and surgical procedures, availability of skilled healthcare professionals and higher disposable income. Also, high prevalence of cardiovascular disease and cancer patients and increasing need for better treatment option boosts the growth of North America transcatheter market throughout the forecast period. Europe is expected to account for the second largest share in the global transcatheter devices market owing to the favorable reimbursement policies, presence of large patient pool and high awareness regarding minimally invasive surgeries such as transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation (TAVI). Shifting preference towards transcatheter replacement procedures over conventional surgeries is one of the prime factors responsible for the market growth during the forecast period. However, Asia Pacific is forecasted to have the highest growth rate in the global market during the forecast period and further expected to plan an important role in the development of the market in the region in future owing to increase in awareness for minimally invasive surgeries in the region.

In 2018, transcatheter replacement device shave dominated the product type segment and is projected to maintain its dominance over the forecast period from 2019 to 2026. The growth of this segment is attributed to the availability of wide range of products and high commercialization rate. Within this segment, the transcatheter aortic valve replacement (TAVR) devices and transcatheter mitral valve replacement accounts for the highest share in the market owing to the increasing demand for TAVR surgeries in developed economies and growing research and development activities by conducted by few of the key players in the market. For instance, Abbott received a FDA approval for fourth-generation MitraClip device - MitraClip G4 in 2018, which offers a wide range of clip sizes, and facilitates real time assessment of procedure, which enable doctors to treat mitral valve disease efficiently.

Cardiovascular application segment dominated the transcatheter devices market on the basis of application in the year 2018. The factors responsible for the growth of this segment includes, growing geriatric population with high risk for cardiac disease and increasing need for advance surgical option for the patients with cardiac disease which offers minimal risk and shorter recovery time. Oncology application segment held second largest share in the global transcatheter market owing to the large patient pool, increasing adoption of embolization technique for cancer such as kidney, pancreatic, breast and liver cancer.

Some of the leading competitors are Abbott, CryoLife, Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, JenaValve Technology, Inc., Meril Lifesciences Pvt. Ltd., Neovasc Inc., and Terumo Corporation. Key strategies followed by the top companies are product launch and marketing authorization. In 2019, companies such as Meril Lifescience, BioVentrix and Edwards Lifesciences received CE approval for their products.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/transcatheter-devices-market

Some of the key observations regarding transcatheter devices industry include:

  • November 2019, MyVal-1 transcatheter heart valve (THV) manufactured by Indian medtech company Meril’s has demonstrated a high procedural success rate in a one-month clinical trial. Myval THV is expected to be the a next-generation TAVR system which is would be minimizing physicians’ learning curve and most of unmet needs
  • In November 2019, U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation status for BioVentrix's Revivent TC™ Transcatheter Ventricular Enhancement System for heart failure. The goal of the Breakthrough Devices Program is to provide patients and health care providers with timely access to these medical devices by speeding up their development, assessment.
  • In November 2019, Edwards Life-sciences received CE Mark approval for expanded use of its Sapien 3 transcatheter aortic valve implantation (TAVI) system.
  • In August 2019, U.S. Food and Drug Administration approved the expansion of the indication for several transcatheter heart valves to patients at low risk for death or major complications associated with open-heart surgery. This new approval would significantly expand the number of patients which can be treated with this minimally invasive procedure for aortic valve replacement
  • In June 2019, an India based company Meril Life Sciences’s Myval Transcatheter Heart Valve receives CE approval. The CE certification would enable MyvalTM -THV to reach over 60 countries in Europe
  • In July 2019, Shanghai MicroPort CardioFlow Medtech Co., Ltd. received the registration certificate for the VitaFlow® Transcatheter Aortic Valve and Delivery System (“VitaFlow®”) from National Medical Products Administration of China (NMPA).

Market Segmentation

Market By Product


  • Transcatheter embolization and occlusion devices
    Coil
    Non Coil


  • Transcatheter replacement devices
    Transcatheter aortic valve replacement devices
    Transcatheter pulmonary valve replacement
    Transcatheter mitral valve replacement


  • Transcatheter repair devices
    Transcatheter mitral valve repair
    Transcatheter tricuspid valve repair

Market By Application

  • Cardiovascular
  • Oncology
  • Neurology
  • Urology
  • Others

Market By Geography


  • North America
    U.S.
    Canada


  • Europe
    UK
    Germany
    France
    Spain
    Rest of Europe


  • Asia-Pacific
    China
    Japan
    India
    Australia
    South Korea
    Rest of Asia-Pacific


  • Latin America
    Brazil
    Mexico
    Rest of Latin America


  • Middle East & Africa
    GCC
    South Africa
    Rest of Middle East & Africa

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Transcatheter devices
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Transcatheter Devices Market By Product Type
1.2.2.1. Global Transcatheter Devices Market Revenue and Growth Rate Comparison By Product Type (2015-2026)
1.2.2.2. Global Transcatheter Devices Market Revenue Share By Product Type in 2017
1.2.2.3. Transcatheter Embolization and Occlusion Devices
1.2.2.3.1. Coil
1.2.2.3.2. Non-Coil
1.2.2.4. Transcatheter Replacement Devices
1.2.2.4.1. Transcatheter Pulmonary Valve Replacement
1.2.2.4.2. Transcatheter Aortic Valve Replacement Devices
1.2.2.4.3. Transcatheter Mitral Valve Replacement
1.2.2.5. Transcatheter Repair Devices
1.2.2.5.1. Transcatheter Mitral Valve Repair
1.2.2.6. Transcatheter Tricuspid Valve Repair
1.2.3. Transcatheter Devices Market By Application
1.2.3.1. Global Transcatheter Devices Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Global Transcatheter Devices Market Revenue Share By Application in 2017
1.2.3.3. Cardiovascular
1.2.3.4. Oncology
1.2.3.5. Neurology
1.2.3.6. Urology
1.2.3.7. Others
1.2.4. Transcatheter Devices Market By Geography
1.2.4.1. Global Transcatheter Devices Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Transcatheter Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Transcatheter Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Transcatheter Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Transcatheter Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Transcatheter Devices Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. TRANSCATHETER DEVICES MARKET BY PRODUCT TYPE
3.1. Global Transcatheter Devices Revenue By Product Type
3.2. Transcatheter Embolization and Occlusion Devices
3.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
3.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
3.3. Transcatheter Replacement Devices
3.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
3.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
3.4. Transcatheter Repair Devices
3.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
3.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
3.5. Others
3.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
3.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 4. TRANSCATHETER DEVICES MARKET BY APPLICATION
4.1. Global Transcatheter Devices Revenue By Application
4.2. Cardiovascular
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Oncology
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Neurology
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Urology
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Others
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. NORTH AMERICA TRANSCATHETER DEVICES MARKET BY COUNTRY
5.1. North America Transcatheter Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2. North America Transcatheter Devices Market Revenue Share Comparison, 2015 & 2026 (%)
5.3. U.S.
5.3.1. U.S. Transcatheter Devices Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.4. Canada
5.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 6. EUROPE TRANSCATHETER DEVICES MARKET BY COUNTRY
6.1. Europe Transcatheter Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. Europe Transcatheter Devices Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. UK
6.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.4. Germany
6.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.5. France
6.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.6. Spain
6.6.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.7. Rest of Europe
6.7.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
6.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 7. ASIA-PACIFIC TRANSCATHETER DEVICES MARKET BY COUNTRY
7.1. Asia-Pacific Transcatheter Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Asia-Pacific Transcatheter Devices Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. China
7.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Japan
7.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. India
7.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.6. Australia
7.6.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.7. South Korea
7.7.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.8. Rest of Asia-Pacific
7.8.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. LATIN AMERICA TRANSCATHETER DEVICES MARKET BY COUNTRY
8.1. Latin America Transcatheter Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Latin America Transcatheter Devices Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. Brazil
8.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Mexico
8.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. Rest of Latin America
8.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET BY COUNTRY
9.1. Middle East & Africa Transcatheter Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Middle East & Africa Transcatheter Devices Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. GCC
9.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. Saudi Africa
9.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. Rest of Middle East & Africa
9.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. COMPANY PROFILE
10.1. Abbott
10.1.1. Company Snapshot
10.1.2. Overview
10.1.3. Financial Overview
10.1.4. Product Portfolio
10.1.5. Key Developments
10.1.6. Strategies
10.2. Cryolife, Inc
10.2.1. Company Snapshot
10.2.2. Overview
10.2.3. Financial Overview
10.2.4. Product Portfolio
10.2.5. Key Developments
10.2.6. Strategies
10.3. Edwards Lifesciences Corporation
10.3.1. Company Snapshot
10.3.2. Overview
10.3.3. Financial Overview
10.3.4. Product Portfolio
10.3.5. Key Developments
10.3.6. Strategies
10.4. Medtronic
10.4.1. Company Snapshot
10.4.2. Overview
10.4.3. Financial Overview
10.4.4. Product Portfolio
10.4.5. Key Developments
10.4.6. Strategies
10.5. Meril Life Sciences Pvt. Ltd.
10.5.1. Company Snapshot
10.5.2. Overview
10.5.3. Financial Overview
10.5.4. Product Portfolio
10.5.5. Key Developments
10.5.6. Strategies
10.6. Stryker
10.6.1. Company Snapshot
10.6.2. Overview
10.6.3. Financial Overview
10.6.4. Product Portfolio
10.6.5. Key Developments
10.6.6. Strategies
10.7. Boston Scientific Corporation
10.7.1. Company Snapshot
10.7.2. Overview
10.7.3. Financial Overview
10.7.4. Product Portfolio
10.7.5. Key Developments
10.7.6. Strategies
10.8. Terumo Corporation
10.8.1. Company Snapshot
10.8.2. Overview
10.8.3. Financial Overview
10.8.4. Product Portfolio
10.8.5. Key Developments
10.8.6. Strategies
10.9. Neovasc Inc.
10.9.1. Company Snapshot
10.9.2. Overview
10.9.3. Financial Overview
10.9.4. Product Portfolio
10.9.5. Key Developments
10.9.6. Strategies
10.10. Jenavalve Technology, Inc
10.10.1. Company Snapshot
10.10.2. Overview
10.10.3. Financial Overview
10.10.4. Product Portfolio
10.10.5. Key Developments
10.10.6. Strategies
10.11. Others
10.11.1. Company Snapshot
10.11.2. Overview
10.11.3. Financial Overview
10.11.4. Product Portfolio
10.11.5. Key Developments
10.11.6. Strategies

CHAPTER 11. RESEARCH APPROACH
11.1. Research Methodology
11.1.1. Initial Data Search
11.1.2. Secondary Research
11.1.3. Primary Research
11.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report@ https://www.acumenresearchandconsulting.com/buy-now/0/1659

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Acumen Research
January 10, 2020, 10:01
0 reactions
0 views